FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Why would a patient trust a peptide more than a statin? STAT The Food and Drug Administration will hold a meeting this summer to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular 2026 predictions: historic FDA shift, plausible mechanisms, bespoke tx, RFK Jr., biotechs, state AGs, peptides, embryos The Niche